{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:28:32Z","timestamp":1757618912324,"version":"3.44.0"},"reference-count":18,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2023,1,23]]},"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1136\/ejhpharm-2022-003487","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T13:20:48Z","timestamp":1675862448000},"page":"363-368","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-\u03b2-cyclodextrins"],"prefix":"10.1136","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1237-7265","authenticated-orcid":false,"given":"Louise","family":"Parrenne","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Armand Trousseau Hospital, Assistance Publique des H\u00f4pitaux de Paris (AP-HP), Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-370X","authenticated-orcid":false,"given":"Zo\u00e9","family":"Ribier","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Armand Trousseau Hospital, Assistance Publique des H\u00f4pitaux de Paris (AP-HP), Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Abisror","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Armand Trousseau Hospital, Assistance Publique des H\u00f4pitaux de Paris (AP-HP), Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jules","family":"Cadix","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Armand Trousseau Hospital, Assistance Publique des H\u00f4pitaux de Paris (AP-HP), Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Benoit","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Armand Trousseau Hospital, Assistance Publique des H\u00f4pitaux de Paris (AP-HP), Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joelle","family":"Bordenave","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Armand Trousseau Hospital, Assistance Publique des H\u00f4pitaux de Paris (AP-HP), Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"2025090703470069000_31.4.363.1","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - GARDENAL 10 mg, comprim\u00e9 - base de donn\u00e9es publique des m\u00e9dicaments. Available: https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=63707416&typedoc=R [Accessed 10 Apr 2022]."},{"key":"2025090703470069000_31.4.363.2","unstructured":"Inserm . \u00c9pilepsie \u22c5 inserm, la science pour la sant\u00e9. Available: https:\/\/www.inserm.fr\/dossier\/epilepsie\/ [Accessed 10 Apr 2022]."},{"key":"2025090703470069000_31.4.363.3","unstructured":"Officine_Pharma_2019_Preparations_Magistrales.pdf. Available: https:\/\/www.nouvelle-aquitaine.ars.sante.fr\/system\/files\/2019-01\/Officine_Pharma_2019_Preparations_Magistrales.pdf [Accessed 10 Apr 2022]."},{"key":"2025090703470069000_31.4.363.4","first-page":"111","article-title":"Flavouring and taste evaluation of an oral paediatric solution of phenobarbital","volume":"26","author":"Giorgi","year":"2007","journal-title":"Journal de Pharmacie Clinique"},{"key":"2025090703470069000_31.4.363.5","unstructured":"Annex-european-commission-guideline-excipients-labelling-package-leaflet-medicinal-products-human_en.pdf. Available: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/annex-european-commission-guideline-excipients-labelling-package-leaflet-medicinal-products-human_en.pdf [Accessed 10 Apr 2022]."},{"key":"2025090703470069000_31.4.363.6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1208\/s12249-008-9112-2","article-title":"Development and chemical stability studies of alcohol-free phenobarbital solution for use in pediatrics: a technical note","volume":"9","author":"Jelveghari","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"2025090703470069000_31.4.363.7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1008770519585","article-title":"Oral bioavailability of phenobarbital: a comparison of a solution in myvacet 9-08, a suspension, and a tablet","volume":"22","author":"Yska","year":"2000","journal-title":"Pharm World Sci"},{"key":"2025090703470069000_31.4.363.8","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jps.1072","article-title":"Multimodal inclusion complexes between barbiturates and 2-hydroxypropyl-beta-cyclodextrin in aqueous solution: isothermal titration microcalorimetry, (13) C NMR spectrometry, and molecular dynamics simulation","volume":"90","author":"Aki","year":"2001","journal-title":"J Pharm Sci"},{"key":"2025090703470069000_31.4.363.9","doi-asserted-by":"crossref","first-page":"111298","DOI":"10.1016\/j.colsurfb.2020.111298","article-title":"Evaluation of anticancer activity of honokiol by complexation with hydroxypropyl-\u03b2-cyclodextrin","volume":"196","author":"Wu","year":"2020","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2025090703470069000_31.4.363.10","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3109\/03639045.2012.696654","article-title":"A new reconstitutable oral paediatric hydrocortisone solution containing hydroxypropyl-\u03b2-cyclodextrin","volume":"39","author":"Orlu-Gul","year":"2013","journal-title":"Drug Dev Ind Pharm"},{"key":"2025090703470069000_31.4.363.11","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.8.603.31529"},{"key":"2025090703470069000_31.4.363.12","unstructured":"Sautou . Guide m\u00e9thodologique des \u00e9tudes de stabilit\u00e9 des pr\u00e9parations. 2013. Available: https:\/\/www.gerpac.eu\/IMG\/pdf\/guide_de_stabilite_vf_avril2013.pdf [Accessed 10 Apr 2022]."},{"key":"2025090703470069000_31.4.363.13","unstructured":"ICH Q 3 B (R2) impurities in new drug products. 2006. Available: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-q-3-b-r2-impurities-new-drug-products-step-5_en.pdf [Accessed 10 Apr 2022]."},{"key":"2025090703470069000_31.4.363.14","unstructured":"De Villiers M . Chapter 18: buffers and ph adjusting agents. In: A Practical Guide to Contemporary Pharmacy Practice. Lippincott Williams & Wilkins, n.d.: 224\u201330."},{"key":"2025090703470069000_31.4.363.15","unstructured":"PubChem . Phenobarbital. Available: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/4763 [Accessed 10 Apr 2022]."},{"key":"2025090703470069000_31.4.363.16","unstructured":"KLEPTOSE HP oral grade. Available: https:\/\/www.roquette.com\/innovation-hub\/pharma\/product-profile-pages\/kleptose-hp-oral-grade [Accessed 10 Apr 2022]."},{"key":"2025090703470069000_31.4.363.17","doi-asserted-by":"publisher","DOI":"10.1208\/pt060243"},{"key":"2025090703470069000_31.4.363.18","unstructured":"ICH Q 1 A stability testing of new drug substances and products. 2003. Available: https:\/\/database.ich.org\/sites\/default\/files\/Q1A%28R2%29%20Guideline.pdf [Accessed 19 Oct 2022]."}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2022-003487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:47:11Z","timestamp":1757242031000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2022-003487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,6,21]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/ejhpharm-2022-003487"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2022-003487","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2023,2,8]]}}}